nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—Sulfonamides—Diclofenamide—glaucoma	0.46	0.569	CiPCiCtD
Sulfamethoxazole—Sulfonamides—Acetazolamide—glaucoma	0.348	0.431	CiPCiCtD
Sulfamethoxazole—CYP2C9—Diclofenamide—glaucoma	0.0146	0.167	CbGbCtD
Sulfamethoxazole—CYP2C9—Dorzolamide—glaucoma	0.0141	0.162	CbGbCtD
Sulfamethoxazole—CYP2C9—Methazolamide—glaucoma	0.0126	0.144	CbGbCtD
Sulfamethoxazole—CYP3A4—Pilocarpine—glaucoma	0.0108	0.124	CbGbCtD
Sulfamethoxazole—CYP3A4—Brinzolamide—glaucoma	0.00851	0.0973	CbGbCtD
Sulfamethoxazole—CYP3A4—Dorzolamide—glaucoma	0.00821	0.094	CbGbCtD
Sulfamethoxazole—CYP3A4—Methazolamide—glaucoma	0.00732	0.0838	CbGbCtD
Sulfamethoxazole—CYP3A4—Acetazolamide—glaucoma	0.00585	0.067	CbGbCtD
Sulfamethoxazole—CYP3A4—Clonidine—glaucoma	0.00529	0.0606	CbGbCtD
Sulfamethoxazole—Rash—Methazolamide—glaucoma	0.000104	0.00117	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methazolamide—glaucoma	0.000104	0.00117	CcSEcCtD
Sulfamethoxazole—Eye disorder—Clonidine—glaucoma	0.000104	0.00117	CcSEcCtD
Sulfamethoxazole—Nausea—Carbachol—glaucoma	0.000104	0.00117	CcSEcCtD
Sulfamethoxazole—Tinnitus—Clonidine—glaucoma	0.000104	0.00117	CcSEcCtD
Sulfamethoxazole—Headache—Methazolamide—glaucoma	0.000103	0.00116	CcSEcCtD
Sulfamethoxazole—Arthralgia—Pilocarpine—glaucoma	0.000103	0.00116	CcSEcCtD
Sulfamethoxazole—Myalgia—Pilocarpine—glaucoma	0.000103	0.00116	CcSEcCtD
Sulfamethoxazole—Nausea—Levobunolol—glaucoma	0.000102	0.00115	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Travoprost—glaucoma	0.000102	0.00115	CcSEcCtD
Sulfamethoxazole—Sulfanilamide—CA2—glaucoma	0.000102	0.781	CrCbGaD
Sulfamethoxazole—Skin disorder—Travoprost—glaucoma	0.000101	0.00114	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Apraclonidine—glaucoma	0.000101	0.00114	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Brinzolamide—glaucoma	0.000101	0.00114	CcSEcCtD
Sulfamethoxazole—Rash—Latanoprost—glaucoma	0.000101	0.00113	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Betaxolol—glaucoma	0.000101	0.00113	CcSEcCtD
Sulfamethoxazole—Dermatitis—Latanoprost—glaucoma	0.000101	0.00113	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Acetazolamide—glaucoma	0.000101	0.00113	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Clonidine—glaucoma	0.0001	0.00113	CcSEcCtD
Sulfamethoxazole—Headache—Latanoprost—glaucoma	0.0001	0.00113	CcSEcCtD
Sulfamethoxazole—Skin disorder—Brinzolamide—glaucoma	0.0001	0.00113	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Brimonidine—glaucoma	0.0001	0.00112	CcSEcCtD
Sulfamethoxazole—Anorexia—Dorzolamide—glaucoma	9.99e-05	0.00112	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Acetazolamide—glaucoma	9.94e-05	0.00112	CcSEcCtD
Sulfamethoxazole—Insomnia—Brimonidine—glaucoma	9.93e-05	0.00112	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Acetazolamide—glaucoma	9.87e-05	0.00111	CcSEcCtD
Sulfamethoxazole—Fatigue—Acetazolamide—glaucoma	9.86e-05	0.00111	CcSEcCtD
Sulfamethoxazole—Nausea—Methazolamide—glaucoma	9.81e-05	0.0011	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Brimonidine—glaucoma	9.78e-05	0.0011	CcSEcCtD
Sulfamethoxazole—Mental disorder—Clonidine—glaucoma	9.75e-05	0.0011	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Pilocarpine—glaucoma	9.7e-05	0.00109	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Brimonidine—glaucoma	9.66e-05	0.00109	CcSEcCtD
Sulfamethoxazole—Hallucination—Betaxolol—glaucoma	9.64e-05	0.00108	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Dorzolamide—glaucoma	9.55e-05	0.00107	CcSEcCtD
Sulfamethoxazole—Tension—Clonidine—glaucoma	9.51e-05	0.00107	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Travoprost—glaucoma	9.51e-05	0.00107	CcSEcCtD
Sulfamethoxazole—Insomnia—Dorzolamide—glaucoma	9.48e-05	0.00107	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Brimonidine—glaucoma	9.47e-05	0.00107	CcSEcCtD
Sulfamethoxazole—Fatigue—Brimonidine—glaucoma	9.46e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Anorexia—Pilocarpine—glaucoma	9.44e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Apraclonidine—glaucoma	9.42e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Nervousness—Clonidine—glaucoma	9.41e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Brinzolamide—glaucoma	9.39e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Dorzolamide—glaucoma	9.34e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Insomnia—Brinzolamide—glaucoma	9.32e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Travoprost—glaucoma	9.3e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Dorzolamide—glaucoma	9.23e-05	0.00104	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Brinzolamide—glaucoma	9.19e-05	0.00103	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Travoprost—glaucoma	9.19e-05	0.00103	CcSEcCtD
Sulfamethoxazole—Asthenia—Apraclonidine—glaucoma	9.17e-05	0.00103	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dorzolamide—glaucoma	9.11e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Urticaria—Acetazolamide—glaucoma	9.08e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Brinzolamide—glaucoma	9.07e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Eye disorder—Betaxolol—glaucoma	9.06e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Pruritus—Apraclonidine—glaucoma	9.04e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Acetazolamide—glaucoma	9.04e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Fatigue—Dorzolamide—glaucoma	9.04e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Tinnitus—Betaxolol—glaucoma	9.04e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Pilocarpine—glaucoma	9.02e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Travoprost—glaucoma	9.01e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Fatigue—Travoprost—glaucoma	9e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Insomnia—Pilocarpine—glaucoma	8.96e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Brinzolamide—glaucoma	8.96e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Brinzolamide—glaucoma	8.9e-05	0.001	CcSEcCtD
Sulfamethoxazole—Asthenia—Bimatoprost—glaucoma	8.89e-05	0.001	CcSEcCtD
Sulfamethoxazole—Fatigue—Brinzolamide—glaucoma	8.88e-05	0.000999	CcSEcCtD
Sulfamethoxazole—Angioedema—Clonidine—glaucoma	8.85e-05	0.000995	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Pilocarpine—glaucoma	8.83e-05	0.000993	CcSEcCtD
Sulfamethoxazole—Depression—Timolol—glaucoma	8.79e-05	0.000989	CcSEcCtD
Sulfamethoxazole—Pruritus—Bimatoprost—glaucoma	8.77e-05	0.000986	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Betaxolol—glaucoma	8.75e-05	0.000984	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Apraclonidine—glaucoma	8.75e-05	0.000983	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Betaxolol—glaucoma	8.73e-05	0.000982	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Pilocarpine—glaucoma	8.72e-05	0.00098	CcSEcCtD
Sulfamethoxazole—Chills—Betaxolol—glaucoma	8.7e-05	0.000978	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Pilocarpine—glaucoma	8.61e-05	0.000968	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dorzolamide—glaucoma	8.57e-05	0.000964	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Pilocarpine—glaucoma	8.55e-05	0.000961	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Travoprost—glaucoma	8.53e-05	0.000959	CcSEcCtD
Sulfamethoxazole—Mental disorder—Betaxolol—glaucoma	8.49e-05	0.000955	CcSEcCtD
Sulfamethoxazole—Cough—Clonidine—glaucoma	8.46e-05	0.000951	CcSEcCtD
Sulfamethoxazole—Dizziness—Apraclonidine—glaucoma	8.45e-05	0.00095	CcSEcCtD
Sulfamethoxazole—Malnutrition—Betaxolol—glaucoma	8.44e-05	0.000948	CcSEcCtD
Sulfamethoxazole—Urticaria—Dorzolamide—glaucoma	8.33e-05	0.000936	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dorzolamide—glaucoma	8.29e-05	0.000931	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dorzolamide—glaucoma	8.29e-05	0.000931	CcSEcCtD
Sulfamethoxazole—Tension—Betaxolol—glaucoma	8.28e-05	0.000931	CcSEcCtD
Sulfamethoxazole—Arthralgia—Clonidine—glaucoma	8.25e-05	0.000927	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Travoprost—glaucoma	8.25e-05	0.000927	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Timolol—glaucoma	8.23e-05	0.000925	CcSEcCtD
Sulfamethoxazole—Asthenia—Acetazolamide—glaucoma	8.2e-05	0.000922	CcSEcCtD
Sulfamethoxazole—Dizziness—Bimatoprost—glaucoma	8.2e-05	0.000921	CcSEcCtD
Sulfamethoxazole—Nervousness—Betaxolol—glaucoma	8.19e-05	0.000921	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	8.19e-05	0.000921	CcSEcCtD
Sulfamethoxazole—Urticaria—Brinzolamide—glaucoma	8.19e-05	0.00092	CcSEcCtD
Sulfamethoxazole—Vomiting—Apraclonidine—glaucoma	8.13e-05	0.000914	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Pilocarpine—glaucoma	8.1e-05	0.00091	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Brimonidine—glaucoma	8.09e-05	0.000909	CcSEcCtD
Sulfamethoxazole—Dermatitis—Apraclonidine—glaucoma	8.05e-05	0.000905	CcSEcCtD
Sulfamethoxazole—Headache—Apraclonidine—glaucoma	8.01e-05	0.0009	CcSEcCtD
Sulfamethoxazole—Hallucination—Timolol—glaucoma	7.88e-05	0.000886	CcSEcCtD
Sulfamethoxazole—Asthenia—Brimonidine—glaucoma	7.87e-05	0.000885	CcSEcCtD
Sulfamethoxazole—UGT1A9—NRF2 pathway—SLC6A1—glaucoma	7.84e-05	0.00512	CbGpPWpGaD
Sulfamethoxazole—Body temperature increased—Pilocarpine—glaucoma	7.83e-05	0.00088	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Pilocarpine—glaucoma	7.83e-05	0.00088	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Acetazolamide—glaucoma	7.82e-05	0.00088	CcSEcCtD
Sulfamethoxazole—Rash—Bimatoprost—glaucoma	7.81e-05	0.000879	CcSEcCtD
Sulfamethoxazole—Dermatitis—Bimatoprost—glaucoma	7.81e-05	0.000878	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Timolol—glaucoma	7.78e-05	0.000875	CcSEcCtD
Sulfamethoxazole—Pruritus—Brimonidine—glaucoma	7.76e-05	0.000873	CcSEcCtD
Sulfamethoxazole—Headache—Bimatoprost—glaucoma	7.76e-05	0.000873	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Clonidine—glaucoma	7.76e-05	0.000872	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Clonidine—glaucoma	7.74e-05	0.000871	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Dorzolamide—glaucoma	7.72e-05	0.000868	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Travoprost—glaucoma	7.69e-05	0.000864	CcSEcCtD
Sulfamethoxazole—Skin disorder—Clonidine—glaucoma	7.68e-05	0.000864	CcSEcCtD
Sulfamethoxazole—Nausea—Apraclonidine—glaucoma	7.59e-05	0.000854	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Brinzolamide—glaucoma	7.59e-05	0.000853	CcSEcCtD
Sulfamethoxazole—Vertigo—Betaxolol—glaucoma	7.58e-05	0.000852	CcSEcCtD
Sulfamethoxazole—Dizziness—Acetazolamide—glaucoma	7.56e-05	0.00085	CcSEcCtD
Sulfamethoxazole—Anorexia—Clonidine—glaucoma	7.54e-05	0.000848	CcSEcCtD
Sulfamethoxazole—Asthenia—Dorzolamide—glaucoma	7.52e-05	0.000845	CcSEcCtD
Sulfamethoxazole—Asthenia—Travoprost—glaucoma	7.49e-05	0.000842	CcSEcCtD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.47e-05	0.00488	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Dorzolamide—glaucoma	7.42e-05	0.000834	CcSEcCtD
Sulfamethoxazole—Eye disorder—Timolol—glaucoma	7.4e-05	0.000832	CcSEcCtD
Sulfamethoxazole—Asthenia—Brinzolamide—glaucoma	7.39e-05	0.000831	CcSEcCtD
Sulfamethoxazole—Pruritus—Travoprost—glaucoma	7.38e-05	0.00083	CcSEcCtD
Sulfamethoxazole—Tinnitus—Timolol—glaucoma	7.38e-05	0.00083	CcSEcCtD
Sulfamethoxazole—Cough—Betaxolol—glaucoma	7.36e-05	0.000828	CcSEcCtD
Sulfamethoxazole—Nausea—Bimatoprost—glaucoma	7.36e-05	0.000828	CcSEcCtD
Sulfamethoxazole—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.31e-05	0.00478	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Pilocarpine—glaucoma	7.3e-05	0.00082	CcSEcCtD
Sulfamethoxazole—Pruritus—Brinzolamide—glaucoma	7.29e-05	0.00082	CcSEcCtD
Sulfamethoxazole—Vomiting—Acetazolamide—glaucoma	7.27e-05	0.000817	CcSEcCtD
Sulfamethoxazole—Dizziness—Brimonidine—glaucoma	7.26e-05	0.000816	CcSEcCtD
Sulfamethoxazole—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	7.25e-05	0.00474	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Clonidine—glaucoma	7.21e-05	0.00081	CcSEcCtD
Sulfamethoxazole—Arthralgia—Betaxolol—glaucoma	7.18e-05	0.000807	CcSEcCtD
Sulfamethoxazole—Myalgia—Betaxolol—glaucoma	7.18e-05	0.000807	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dorzolamide—glaucoma	7.17e-05	0.000806	CcSEcCtD
Sulfamethoxazole—Headache—Acetazolamide—glaucoma	7.16e-05	0.000805	CcSEcCtD
Sulfamethoxazole—Insomnia—Clonidine—glaucoma	7.15e-05	0.000804	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Timolol—glaucoma	7.15e-05	0.000804	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Travoprost—glaucoma	7.14e-05	0.000803	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Timolol—glaucoma	7.14e-05	0.000802	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	7.13e-05	0.000802	CcSEcCtD
Sulfamethoxazole—Asthenia—Pilocarpine—glaucoma	7.11e-05	0.000799	CcSEcCtD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	7.08e-05	0.00463	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—GSTT1—glaucoma	7.08e-05	0.00463	CbGpPWpGaD
Sulfamethoxazole—Dyspnoea—Clonidine—glaucoma	7.05e-05	0.000793	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Brinzolamide—glaucoma	7.05e-05	0.000793	CcSEcCtD
Sulfamethoxazole—Pruritus—Pilocarpine—glaucoma	7.01e-05	0.000788	CcSEcCtD
Sulfamethoxazole—Mental disorder—Timolol—glaucoma	6.94e-05	0.00078	CcSEcCtD
Sulfamethoxazole—Dizziness—Dorzolamide—glaucoma	6.93e-05	0.000779	CcSEcCtD
Sulfamethoxazole—Rash—Brimonidine—glaucoma	6.92e-05	0.000778	CcSEcCtD
Sulfamethoxazole—Dermatitis—Brimonidine—glaucoma	6.91e-05	0.000777	CcSEcCtD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—TXN—glaucoma	6.9e-05	0.00451	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Travoprost—glaucoma	6.9e-05	0.000776	CcSEcCtD
Sulfamethoxazole—Malnutrition—Timolol—glaucoma	6.89e-05	0.000775	CcSEcCtD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	6.89e-05	0.0045	CbGpPWpGaD
Sulfamethoxazole—Headache—Brimonidine—glaucoma	6.88e-05	0.000773	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Clonidine—glaucoma	6.87e-05	0.000773	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Clonidine—glaucoma	6.83e-05	0.000768	CcSEcCtD
Sulfamethoxazole—Fatigue—Clonidine—glaucoma	6.82e-05	0.000767	CcSEcCtD
Sulfamethoxazole—UGT1A9—PPARA activates gene expression—ABCA1—glaucoma	6.82e-05	0.00445	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Brinzolamide—glaucoma	6.81e-05	0.000766	CcSEcCtD
Sulfamethoxazole—Nausea—Acetazolamide—glaucoma	6.79e-05	0.000764	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Pilocarpine—glaucoma	6.78e-05	0.000762	CcSEcCtD
Sulfamethoxazole—Tension—Timolol—glaucoma	6.76e-05	0.00076	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Betaxolol—glaucoma	6.75e-05	0.000759	CcSEcCtD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	6.74e-05	0.00441	CbGpPWpGaD
Sulfamethoxazole—Thrombocytopenia—Betaxolol—glaucoma	6.74e-05	0.000758	CcSEcCtD
Sulfamethoxazole—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	6.71e-05	0.00438	CbGpPWpGaD
Sulfamethoxazole—Nervousness—Timolol—glaucoma	6.69e-05	0.000753	CcSEcCtD
Sulfamethoxazole—Skin disorder—Betaxolol—glaucoma	6.69e-05	0.000752	CcSEcCtD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	6.67e-05	0.00436	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Dorzolamide—glaucoma	6.66e-05	0.000749	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	6.64e-05	0.00434	CbGpPWpGaD
Sulfamethoxazole—ALB—Lipoprotein metabolism—APOE—glaucoma	6.64e-05	0.00434	CbGpPWpGaD
Sulfamethoxazole—Rash—Dorzolamide—glaucoma	6.61e-05	0.000743	CcSEcCtD
Sulfamethoxazole—Dermatitis—Dorzolamide—glaucoma	6.6e-05	0.000742	CcSEcCtD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	6.6e-05	0.00431	CbGpPWpGaD
Sulfamethoxazole—Rash—Travoprost—glaucoma	6.58e-05	0.00074	CcSEcCtD
Sulfamethoxazole—Dermatitis—Travoprost—glaucoma	6.57e-05	0.000739	CcSEcCtD
Sulfamethoxazole—Headache—Dorzolamide—glaucoma	6.57e-05	0.000738	CcSEcCtD
Sulfamethoxazole—Anorexia—Betaxolol—glaucoma	6.56e-05	0.000738	CcSEcCtD
Sulfamethoxazole—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	6.55e-05	0.00428	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Brinzolamide—glaucoma	6.55e-05	0.000737	CcSEcCtD
Sulfamethoxazole—Dizziness—Pilocarpine—glaucoma	6.55e-05	0.000736	CcSEcCtD
Sulfamethoxazole—Headache—Travoprost—glaucoma	6.54e-05	0.000735	CcSEcCtD
Sulfamethoxazole—Nausea—Brimonidine—glaucoma	6.52e-05	0.000733	CcSEcCtD
Sulfamethoxazole—UGT1A9—Phase II conjugation—GSTM1—glaucoma	6.51e-05	0.00426	CbGpPWpGaD
Sulfamethoxazole—Rash—Brinzolamide—glaucoma	6.5e-05	0.00073	CcSEcCtD
Sulfamethoxazole—Dermatitis—Brinzolamide—glaucoma	6.49e-05	0.00073	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Clonidine—glaucoma	6.47e-05	0.000727	CcSEcCtD
Sulfamethoxazole—Headache—Brinzolamide—glaucoma	6.45e-05	0.000726	CcSEcCtD
Sulfamethoxazole—UGT1A9—NRF2 pathway—TGFB2—glaucoma	6.39e-05	0.00418	CbGpPWpGaD
Sulfamethoxazole—Angioedema—Timolol—glaucoma	6.3e-05	0.000708	CcSEcCtD
Sulfamethoxazole—Vomiting—Pilocarpine—glaucoma	6.3e-05	0.000708	CcSEcCtD
Sulfamethoxazole—Urticaria—Clonidine—glaucoma	6.28e-05	0.000706	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Betaxolol—glaucoma	6.27e-05	0.000705	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Clonidine—glaucoma	6.25e-05	0.000703	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Clonidine—glaucoma	6.25e-05	0.000703	CcSEcCtD
Sulfamethoxazole—Rash—Pilocarpine—glaucoma	6.24e-05	0.000702	CcSEcCtD
Sulfamethoxazole—Dermatitis—Pilocarpine—glaucoma	6.24e-05	0.000701	CcSEcCtD
Sulfamethoxazole—Insomnia—Betaxolol—glaucoma	6.23e-05	0.0007	CcSEcCtD
Sulfamethoxazole—Nausea—Dorzolamide—glaucoma	6.23e-05	0.0007	CcSEcCtD
Sulfamethoxazole—Headache—Pilocarpine—glaucoma	6.2e-05	0.000697	CcSEcCtD
Sulfamethoxazole—Nausea—Travoprost—glaucoma	6.2e-05	0.000697	CcSEcCtD
Sulfamethoxazole—Vertigo—Timolol—glaucoma	6.19e-05	0.000696	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Betaxolol—glaucoma	6.14e-05	0.00069	CcSEcCtD
Sulfamethoxazole—Nausea—Brinzolamide—glaucoma	6.12e-05	0.000688	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Betaxolol—glaucoma	6.06e-05	0.000681	CcSEcCtD
Sulfamethoxazole—Cough—Timolol—glaucoma	6.01e-05	0.000676	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Betaxolol—glaucoma	5.99e-05	0.000673	CcSEcCtD
Sulfamethoxazole—UGT1A9—Biological oxidations—GSTT1—glaucoma	5.98e-05	0.00391	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal disorder—Betaxolol—glaucoma	5.94e-05	0.000668	CcSEcCtD
Sulfamethoxazole—Fatigue—Betaxolol—glaucoma	5.94e-05	0.000667	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	5.92e-05	0.00387	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CA1—glaucoma	5.88e-05	0.00385	CbGpPWpGaD
Sulfamethoxazole—Nausea—Pilocarpine—glaucoma	5.88e-05	0.000661	CcSEcCtD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	5.88e-05	0.00384	CbGpPWpGaD
Sulfamethoxazole—Myalgia—Timolol—glaucoma	5.87e-05	0.00066	CcSEcCtD
Sulfamethoxazole—Arthralgia—Timolol—glaucoma	5.87e-05	0.00066	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	5.84e-05	0.00382	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.83e-05	0.00381	CbGpPWpGaD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	5.83e-05	0.000655	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Clonidine—glaucoma	5.83e-05	0.000655	CcSEcCtD
Sulfamethoxazole—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.75e-05	0.00376	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CTSA—glaucoma	5.7e-05	0.00372	CbGpPWpGaD
Sulfamethoxazole—Asthenia—Clonidine—glaucoma	5.67e-05	0.000638	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—ABCA1—glaucoma	5.64e-05	0.00369	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CYP1B1—glaucoma	5.64e-05	0.00369	CbGpPWpGaD
Sulfamethoxazole—Anaphylactic shock—Timolol—glaucoma	5.62e-05	0.000632	CcSEcCtD
Sulfamethoxazole—Pruritus—Clonidine—glaucoma	5.6e-05	0.000629	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Timolol—glaucoma	5.52e-05	0.00062	CcSEcCtD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	5.49e-05	0.00359	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	5.49e-05	0.00359	CbGpPWpGaD
Sulfamethoxazole—Urticaria—Betaxolol—glaucoma	5.47e-05	0.000615	CcSEcCtD
Sulfamethoxazole—Skin disorder—Timolol—glaucoma	5.46e-05	0.000614	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Betaxolol—glaucoma	5.44e-05	0.000612	CcSEcCtD
Sulfamethoxazole—ALB—Platelet degranulation—TGFB2—glaucoma	5.41e-05	0.00354	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Clonidine—glaucoma	5.41e-05	0.000608	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—CA2—glaucoma	5.38e-05	0.00352	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—ABCA1—glaucoma	5.37e-05	0.00351	CbGpPWpGaD
Sulfamethoxazole—Anorexia—Timolol—glaucoma	5.36e-05	0.000603	CcSEcCtD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	5.3e-05	0.00346	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Clonidine—glaucoma	5.23e-05	0.000588	CcSEcCtD
Sulfamethoxazole—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	5.17e-05	0.00338	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	5.16e-05	0.00337	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Timolol—glaucoma	5.12e-05	0.000576	CcSEcCtD
Sulfamethoxazole—Insomnia—Timolol—glaucoma	5.09e-05	0.000572	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Betaxolol—glaucoma	5.07e-05	0.00057	CcSEcCtD
Sulfamethoxazole—Vomiting—Clonidine—glaucoma	5.03e-05	0.000565	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Timolol—glaucoma	5.01e-05	0.000564	CcSEcCtD
Sulfamethoxazole—Rash—Clonidine—glaucoma	4.99e-05	0.000561	CcSEcCtD
Sulfamethoxazole—Dermatitis—Clonidine—glaucoma	4.98e-05	0.00056	CcSEcCtD
Sulfamethoxazole—Headache—Clonidine—glaucoma	4.95e-05	0.000557	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Timolol—glaucoma	4.95e-05	0.000557	CcSEcCtD
Sulfamethoxazole—Asthenia—Betaxolol—glaucoma	4.94e-05	0.000555	CcSEcCtD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	4.93e-05	0.00322	CbGpPWpGaD
Sulfamethoxazole—Decreased appetite—Timolol—glaucoma	4.89e-05	0.00055	CcSEcCtD
Sulfamethoxazole—PTGS1—Biological oxidations—GSTT1—glaucoma	4.88e-05	0.00319	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Betaxolol—glaucoma	4.87e-05	0.000548	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Timolol—glaucoma	4.86e-05	0.000546	CcSEcCtD
Sulfamethoxazole—Fatigue—Timolol—glaucoma	4.85e-05	0.000545	CcSEcCtD
Sulfamethoxazole—ALB—Folate Metabolism—SOD1—glaucoma	4.79e-05	0.00313	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—CYP1B1—glaucoma	4.77e-05	0.00312	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.74e-05	0.0031	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.72e-05	0.00309	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Betaxolol—glaucoma	4.71e-05	0.00053	CcSEcCtD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	4.71e-05	0.00308	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CYP1B1—glaucoma	4.7e-05	0.00307	CbGpPWpGaD
Sulfamethoxazole—Nausea—Clonidine—glaucoma	4.7e-05	0.000528	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	4.69e-05	0.00307	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.68e-05	0.00306	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	4.66e-05	0.00305	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal pain—Timolol—glaucoma	4.6e-05	0.000517	CcSEcCtD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	4.6e-05	0.003	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Betaxolol—glaucoma	4.55e-05	0.000512	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—GSTM1—glaucoma	4.51e-05	0.00295	CbGpPWpGaD
Sulfamethoxazole—Urticaria—Timolol—glaucoma	4.47e-05	0.000502	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.45e-05	0.00291	CbGpPWpGaD
Sulfamethoxazole—Abdominal pain—Timolol—glaucoma	4.45e-05	0.0005	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Timolol—glaucoma	4.45e-05	0.0005	CcSEcCtD
Sulfamethoxazole—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	4.41e-05	0.00288	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Betaxolol—glaucoma	4.38e-05	0.000492	CcSEcCtD
Sulfamethoxazole—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	4.37e-05	0.00286	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—GSTM1—glaucoma	4.34e-05	0.00284	CbGpPWpGaD
Sulfamethoxazole—Rash—Betaxolol—glaucoma	4.34e-05	0.000488	CcSEcCtD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—APOE—glaucoma	4.34e-05	0.00284	CbGpPWpGaD
Sulfamethoxazole—Dermatitis—Betaxolol—glaucoma	4.34e-05	0.000488	CcSEcCtD
Sulfamethoxazole—Headache—Betaxolol—glaucoma	4.31e-05	0.000485	CcSEcCtD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	4.27e-05	0.00279	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CA5A—glaucoma	4.19e-05	0.00274	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NARFL—glaucoma	4.19e-05	0.00274	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	4.17e-05	0.00272	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Timolol—glaucoma	4.14e-05	0.000466	CcSEcCtD
Sulfamethoxazole—ALB—Platelet degranulation—SOD1—glaucoma	4.1e-05	0.00268	CbGpPWpGaD
Sulfamethoxazole—Nausea—Betaxolol—glaucoma	4.09e-05	0.00046	CcSEcCtD
Sulfamethoxazole—Asthenia—Timolol—glaucoma	4.04e-05	0.000454	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—MTHFR—glaucoma	3.99e-05	0.00261	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	3.99e-05	0.0026	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Timolol—glaucoma	3.98e-05	0.000447	CcSEcCtD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	3.91e-05	0.00256	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP1B1—glaucoma	3.89e-05	0.00254	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	3.87e-05	0.00253	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Timolol—glaucoma	3.85e-05	0.000433	CcSEcCtD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.85e-05	0.00251	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—GSTM1—glaucoma	3.81e-05	0.00249	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—SOD1—glaucoma	3.8e-05	0.00249	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—MTHFR—glaucoma	3.79e-05	0.00248	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—TXN—glaucoma	3.79e-05	0.00248	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—GSTM1—glaucoma	3.76e-05	0.00246	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Timolol—glaucoma	3.72e-05	0.000418	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—APOE—glaucoma	3.71e-05	0.00243	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CAV1—glaucoma	3.68e-05	0.0024	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.63e-05	0.00237	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Timolol—glaucoma	3.58e-05	0.000402	CcSEcCtD
Sulfamethoxazole—Rash—Timolol—glaucoma	3.55e-05	0.000399	CcSEcCtD
Sulfamethoxazole—Dermatitis—Timolol—glaucoma	3.54e-05	0.000398	CcSEcCtD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	3.53e-05	0.00231	CbGpPWpGaD
Sulfamethoxazole—Headache—Timolol—glaucoma	3.52e-05	0.000396	CcSEcCtD
Sulfamethoxazole—PTGS1—Metabolism—CA5A—glaucoma	3.42e-05	0.00223	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NARFL—glaucoma	3.42e-05	0.00223	CbGpPWpGaD
Sulfamethoxazole—Nausea—Timolol—glaucoma	3.34e-05	0.000376	CcSEcCtD
Sulfamethoxazole—CYP2C8—Biological oxidations—GSTT1—glaucoma	3.15e-05	0.00206	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.13e-05	0.00204	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—GSTM1—glaucoma	3.11e-05	0.00203	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.09e-05	0.00202	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	3.04e-05	0.00199	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	3.01e-05	0.00197	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	2.99e-05	0.00196	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GSTT1—glaucoma	2.94e-05	0.00192	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—FN1—glaucoma	2.86e-05	0.00187	CbGpPWpGaD
Sulfamethoxazole—Dapsone—PTGS2—glaucoma	2.85e-05	0.219	CrCbGaD
Sulfamethoxazole—NAT1—Metabolism—NOS3—glaucoma	2.78e-05	0.00182	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	2.72e-05	0.00178	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.69e-05	0.00176	CbGpPWpGaD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	2.59e-05	0.00169	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GSTT1—glaucoma	2.56e-05	0.00168	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PTGS2—glaucoma	2.54e-05	0.00166	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.54e-05	0.00166	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP1B1—glaucoma	2.51e-05	0.00164	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	2.48e-05	0.00162	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	2.47e-05	0.00162	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	2.4e-05	0.00157	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.34e-05	0.00153	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP1B1—glaucoma	2.34e-05	0.00153	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ABCA1—glaucoma	2.34e-05	0.00153	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.33e-05	0.00152	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NARFL—glaucoma	2.21e-05	0.00144	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CA5A—glaucoma	2.21e-05	0.00144	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NARFL—glaucoma	2.2e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CA5A—glaucoma	2.2e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CA1—glaucoma	2.05e-05	0.00134	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP1B1—glaucoma	2.04e-05	0.00134	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	2.02e-05	0.00132	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	2.01e-05	0.00132	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—TNF—glaucoma	2.01e-05	0.00131	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—GSTM1—glaucoma	2.01e-05	0.00131	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CTSA—glaucoma	1.98e-05	0.0013	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	1.98e-05	0.00129	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	1.92e-05	0.00126	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.91e-05	0.00125	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CA2—glaucoma	1.87e-05	0.00122	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GSTM1—glaucoma	1.87e-05	0.00122	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.83e-05	0.0012	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.83e-05	0.0012	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	1.82e-05	0.00119	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CA5A—glaucoma	1.8e-05	0.00117	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NARFL—glaucoma	1.8e-05	0.00117	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.8e-05	0.00117	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.69e-05	0.00111	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CA1—glaucoma	1.67e-05	0.00109	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—MTHFR—glaucoma	1.66e-05	0.00108	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—VEGFA—glaucoma	1.63e-05	0.00107	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TNF—glaucoma	1.63e-05	0.00107	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GSTM1—glaucoma	1.63e-05	0.00107	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CTSA—glaucoma	1.62e-05	0.00106	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	1.61e-05	0.00105	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	1.56e-05	0.00102	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—APOE—glaucoma	1.54e-05	0.00101	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CAV1—glaucoma	1.53e-05	0.000998	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CA2—glaucoma	1.53e-05	0.000998	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.49e-05	0.000975	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.49e-05	0.000975	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—glaucoma	1.44e-05	0.000941	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.35e-05	0.000881	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.33e-05	0.000868	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—TXN—glaucoma	1.32e-05	0.000862	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.31e-05	0.000859	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—TNF—glaucoma	1.3e-05	0.000848	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	1.27e-05	0.000828	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB2—glaucoma	1.24e-05	0.000809	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.2e-05	0.000787	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.19e-05	0.00078	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NARFL—glaucoma	1.18e-05	0.000775	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CA5A—glaucoma	1.18e-05	0.000775	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—NOS3—glaucoma	1.15e-05	0.000754	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CA1—glaucoma	1.08e-05	0.000705	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.08e-05	0.000704	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—TXN—glaucoma	1.08e-05	0.000703	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CA1—glaucoma	1.07e-05	0.000701	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.06e-05	0.000694	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTGS2—glaucoma	1.06e-05	0.00069	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CTSA—glaucoma	1.04e-05	0.000682	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CTSA—glaucoma	1.04e-05	0.000679	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTT1—glaucoma	1.02e-05	0.000669	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CA2—glaucoma	9.86e-06	0.000645	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.81e-06	0.000641	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CA2—glaucoma	9.8e-06	0.000641	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.72e-06	0.000636	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.64e-06	0.00063	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.64e-06	0.00063	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.58e-06	0.000626	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.58e-06	0.000626	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SOD1—glaucoma	9.38e-06	0.000613	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CA1—glaucoma	8.77e-06	0.000574	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CTSA—glaucoma	8.5e-06	0.000555	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTT1—glaucoma	8.34e-06	0.000545	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.25e-06	0.000539	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP1B1—glaucoma	8.15e-06	0.000533	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ABCA1—glaucoma	8.15e-06	0.000533	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CA2—glaucoma	8.03e-06	0.000525	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.84e-06	0.000513	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.84e-06	0.000513	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	7.25e-06	0.000474	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MMP1—glaucoma	7.16e-06	0.000468	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TXN—glaucoma	6.95e-06	0.000454	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TXN—glaucoma	6.91e-06	0.000452	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CAV1—glaucoma	6.86e-06	0.000448	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.72e-06	0.00044	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP1B1—glaucoma	6.64e-06	0.000434	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ABCA1—glaucoma	6.64e-06	0.000434	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—FN1—glaucoma	6.53e-06	0.000427	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTM1—glaucoma	6.52e-06	0.000426	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.34e-06	0.000414	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.3e-06	0.000412	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.28e-06	0.000411	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.25e-06	0.000408	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CA1—glaucoma	5.79e-06	0.000378	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—MTHFR—glaucoma	5.76e-06	0.000376	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TXN—glaucoma	5.65e-06	0.00037	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CTSA—glaucoma	5.6e-06	0.000366	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTT1—glaucoma	5.39e-06	0.000352	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOE—glaucoma	5.36e-06	0.00035	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTT1—glaucoma	5.36e-06	0.00035	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CAV1—glaucoma	5.31e-06	0.000347	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTM1—glaucoma	5.31e-06	0.000347	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CA2—glaucoma	5.29e-06	0.000346	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS3—glaucoma	5.19e-06	0.000339	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.16e-06	0.000337	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.11e-06	0.000334	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—MTHFR—glaucoma	4.69e-06	0.000307	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTT1—glaucoma	4.38e-06	0.000287	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOE—glaucoma	4.37e-06	0.000286	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.34e-06	0.000284	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CAV1—glaucoma	4.33e-06	0.000283	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.32e-06	0.000282	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1B1—glaucoma	4.29e-06	0.000281	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCA1—glaucoma	4.29e-06	0.000281	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1B1—glaucoma	4.27e-06	0.000279	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCA1—glaucoma	4.27e-06	0.000279	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NOS3—glaucoma	4.02e-06	0.000263	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—glaucoma	3.74e-06	0.000244	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TXN—glaucoma	3.73e-06	0.000244	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—glaucoma	3.67e-06	0.00024	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.54e-06	0.000231	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1B1—glaucoma	3.49e-06	0.000228	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCA1—glaucoma	3.49e-06	0.000228	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—glaucoma	3.43e-06	0.000224	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—glaucoma	3.41e-06	0.000223	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NOS3—glaucoma	3.27e-06	0.000214	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MTHFR—glaucoma	3.03e-06	0.000198	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MTHFR—glaucoma	3.02e-06	0.000197	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—glaucoma	2.99e-06	0.000196	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTT1—glaucoma	2.89e-06	0.000189	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—glaucoma	2.82e-06	0.000185	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOE—glaucoma	2.82e-06	0.000185	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOE—glaucoma	2.81e-06	0.000183	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAV1—glaucoma	2.8e-06	0.000183	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—glaucoma	2.79e-06	0.000183	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAV1—glaucoma	2.78e-06	0.000182	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTHFR—glaucoma	2.47e-06	0.000161	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1B1—glaucoma	2.3e-06	0.000151	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCA1—glaucoma	2.3e-06	0.000151	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOE—glaucoma	2.3e-06	0.00015	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAV1—glaucoma	2.28e-06	0.000149	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NOS3—glaucoma	2.12e-06	0.000138	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NOS3—glaucoma	2.1e-06	0.000137	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—glaucoma	1.93e-06	0.000126	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—glaucoma	1.92e-06	0.000126	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—glaucoma	1.84e-06	0.00012	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NOS3—glaucoma	1.72e-06	0.000113	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTHFR—glaucoma	1.63e-06	0.000106	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—glaucoma	1.57e-06	0.000103	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOE—glaucoma	1.52e-06	9.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAV1—glaucoma	1.5e-06	9.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NOS3—glaucoma	1.14e-06	7.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—glaucoma	1.04e-06	6.79e-05	CbGpPWpGaD
